Sio Gene Therapies Inc. Research and Development in Process
Sio Gene Therapies Inc. reported Research and Development in Process of $0 for the 12-month period ending 2018-03-31, per its 10-K filed 2018-06-11.
Discontinued › Notes
us-gaap:ResearchAndDevelopmentInProcess · last filed 2018-06-11
- Sio Gene Therapies Inc. research and development in process for the quarter ending 2017-03-31 was $0.00.
- Sio Gene Therapies Inc. research and development in process for the quarter ending 2016-03-31 was $0.00.
- Sio Gene Therapies Inc. research and development in process for fiscal 2018 was $0.00.
- Sio Gene Therapies Inc. research and development in process for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Sio Gene Therapies Inc. research and development in process for fiscal 2016 was $5.25M.
| Period end | Research and Development in Process 2 month | Research and Development in Process 3 month | Research and Development in Process 5 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|---|---|
| 2018-03-31 | $0.00 10-K · filed 2018-06-11 | ||||
| 2017-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-11 | $0.00 10-K · filed 2018-06-11 | |||
| 2016-12-31 | $0.00 10-Q · filed 2017-02-14 | ||||
| 2016-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-11 | $5.25M 10-K · filed 2018-06-11 | |||
| 2015-12-31 | $5.25M 10-Q · filed 2017-02-14 | ||||
| 2015-03-31 | $10.00M 10-K · filed 2017-06-13 | ||||
| 2014-12-31 | $10.00M 10-Q · filed 2016-02-09 |